Effect of infection by Mycoplasma arginini and Mycoplasma salivarium on the oncogenic properties of lung cancer cell line A549.

EMT Lung cancer M. arginini M. salivarium Mycoplasma ZEB1 p53

Journal

Biochemical and biophysical research communications
ISSN: 1090-2104
Titre abrégé: Biochem Biophys Res Commun
Pays: United States
ID NLM: 0372516

Informations de publication

Date de publication:
23 Oct 2024
Historique:
received: 16 10 2024
revised: 17 10 2024
accepted: 22 10 2024
medline: 31 10 2024
pubmed: 31 10 2024
entrez: 30 10 2024
Statut: aheadofprint

Résumé

Most mycoplasma species are the extracellular parasites affecting different cellular processes including proliferation, cell cycle, protein synthesis, DNA repair and others. Mycoplasma infection was shown to contribute to the pathology of various diseases, including cancer. Upon infection, mycoplasmas typically activate the tumor-associated NF-kB pathway, which is associated with EMT, the main mechanism of metastasis. In this study, we found that two different mycoplasma strains, M. arginini and M. salivarium, promoted the initiation of EMT and simultaneous suppression of the p53 tumor suppressor in A549 lung cancer cells. This led to an increase of cancer cell motility, resistance to the antitumor drug etoposide concomitantly with decreased autophagy. These data indicate that mycoplasmas are able to increase the tumorigenic potential of cancer host cells.

Identifiants

pubmed: 39476758
pii: S0006-291X(24)01414-1
doi: 10.1016/j.bbrc.2024.150878
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

150878

Informations de copyright

Copyright © 2024 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest Parfenyev S.E. - I have nothing to declare. Vishnyakov I.E. - I have nothing to declare. Efimova T.N. Daks A.A. - I have nothing to declare. Shuvalov O.Y. - I have nothing to declare. Fedorova O.A. - I have nothing to declare. Lomert E.V. - I have nothing to declare. Tentler D.G. - I have nothing to declare. Borchsenius S.N. - I have nothing to declare. Barlev N.A. - I have nothing to declare.

Auteurs

S E Parfenyev (SE)

Institute of Cytology, Russian Academy of Sciences, St. Petersburg, 194064, Russia. Electronic address: gen21eration@gmail.com.

I E Vishnyakov (IE)

Institute of Cytology, Russian Academy of Sciences, St. Petersburg, 194064, Russia.

T N Efimova (TN)

Institute of Cytology, Russian Academy of Sciences, St. Petersburg, 194064, Russia.

A A Daks (AA)

Institute of Cytology, Russian Academy of Sciences, St. Petersburg, 194064, Russia.

O Y Shuvalov (OY)

Institute of Cytology, Russian Academy of Sciences, St. Petersburg, 194064, Russia.

O A Fedorova (OA)

Institute of Cytology, Russian Academy of Sciences, St. Petersburg, 194064, Russia.

E V Lomert (EV)

Institute of Cytology, Russian Academy of Sciences, St. Petersburg, 194064, Russia.

D G Tentler (DG)

Institute of Cytology, Russian Academy of Sciences, St. Petersburg, 194064, Russia.

S N Borchsenius (SN)

Institute of Cytology, Russian Academy of Sciences, St. Petersburg, 194064, Russia.

N A Barlev (NA)

Institute of Cytology, Russian Academy of Sciences, St. Petersburg, 194064, Russia; School of Medicine Nazarbayev University, Astana, 010000, Kazakhstan. Electronic address: nikolai.barlev@nu.edu.kz.

Classifications MeSH